 Company Overview ABT's Operations Leadership History |
Leadership
Jeffery S. Thompson, President, Chairman and CEO
Jeffery S. Thompson is the Operating Partner for HealthEdge Investment Partners' portfolio companies in their Healthcare Products Group. HealthEdge is an operating-oriented private equity firm founded in 2005 that provides strategic capital exclusively in the healthcare industry. Thompson is responsible for managing the portfolio companies of the Healthcare Products Group and currently serves as Chairman and CEO of Advanced Bio-Technologies, Inc. and as Chairman of Woodbury Products, Inc., both HealthEdge Healthcare Products Group portfolio companies. Prior to joining HealthEdge, Thompson was Chief Operating Officer for Stiefel Laboratories, Inc., the world's largest independent pharmaceutical company specializing in dermatology. He continues to serve as a member of Stiefel's Board of Directors. Prior to becoming Stiefel's COO, Thompson served as Stiefel's Senior Vice President U.S. Business Services and President of Glades Pharmaceuticals. During his tenure in this dual leadership role, Glades grew from $36 million to over $73 million. Earlier in his career, Thompson held Sales and Business Management positions at Bausch & Lomb Pharmaceuticals and he began his career at SmithKline Beecham as a Professional Sales Representative. Thompson received his Bachelor's degree in General Science after completing one year of study in Dental Medicine, both at the University of Pittsburgh. You can reach Mr. Thompson at
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Zubin Meshginpoosh, VP of Operations and Professional Sales
Meshginpoosh joins Advanced Bio-Technologies, Inc. with 8 years of pharmaceutical industry experience, in addition to 5 years of operations management experience with United Parcel Service. After leaving UPS, Meshginpoosh started his career in pharmaceuticals with Bayer Corporation as a field sales representative. Meshginpoosh then joined Salix Pharmaceuticals to help build their growing organization, and advanced in areas of responsibility. Meshginpoosh left Salix to help start StoneBridge Pharma, a wholly-owned subsidiary of Stiefel Laboratories, Inc., as Gastrointestinal Marketing Manager. While at StoneBridge, he worked in several cross-functional roles including Business Development and Sales Training. Most recently, Meshginpoosh was with Inspire Pharmaceuticals where he served as Associate Director of Strategic Markets, Marketing and Analytics. Meshginpoosh received his Bachelor's of Science in Science and Mathematics from Bowling Green State University, his M.B.A. in Marketing and International Management at the University of Toledo, and his Master's of Science in Corporate Finance from Walsh College in Troy, Michigan. You can reach Mr. Meshginpoosh at
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Martin E. Floreani, VP of International Sales and Market Development
Mr. Floreani has over fifteen years of management experience, four in consumer sales and marketing and eleven in the pharmaceutical industry. Martin began his career with The Andrew Jergens Company where he opened and managed a regional in South America. Four years later, he took a regional marketing position with Merck & Co (MSD) in Miami. In this role he was responsible for a much larger region in Latin America and launched Propecia®, a prescribed dermatological hair-loss product for men which today represents approximately $400 million. Martin also worked as an office-base sales representative in New York City promoting blockbuster drugs in asthma, cardiovascular, pain/arthritis, and osteoporosis and was awarded many of the company’s highest ranked sales achievements. His achievements resulted in a Global Product Management assignment for Merck’s respiratory division in the New Jersey headquarters as part of a team that managed the marketing strategy for a $US 2.5 billion franchise. In 2004, Martin built and lead a global marketing function at Stiefel laboratories, based in Coral Gables, Florida. Over the next five years he would hold various key roles at Stiefel in marketing and strategy and develop valuable experience in planning, corporate development (particularly M&A), restructuring, and leadership. In July, 2009, Stiefel was acquired by GlaxoSmithKline for $US 3.6 billion, a transaction in which he played a key role as VP of Global Strategy and as part of the company’s core management team. Upon completion of the transaction Martin joined Advanced Bio-Technologies in his current role with P&L responsibility for International. Martin has an MBA in Finance and a BBA in International Finance and Marketing from the University of Miami. You can reach Mr. Floreani at
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Annette Rubin, VP of Consumer Markets, President of Belli Materna
Annette Rubin has 17 years of experience in the cosmetics industry, beginning with executive positions at Estee Lauder Corporation overseeing the Clinique brand. She has also served as the national Clinique-Nordstrom chairperson and worked for May Companies as the assistant fragrance buyer for Famous Barr, LS Ayres and Jones Stores. While pregnant with her son Jackson, Annette recognized a gap in the beauty industry—there were no medically sound products that specifically addressed the unique skin care concerns of pregnancy. Passionate about meeting this need, she asked her family practitioner husband, Jason Rubin, M.D., to review the published medical literature looking for ingredients which were safest for the growing baby. Together, they combined their knowledge into luxurious products that pamper and comfort the expectant mom. Belli launched as a company in 2002, and has quickly grown to become the premier pregnancy skin care brand in the United States with expanding international distribution. Annette and Jason are now respected as leading experts in the pregnancy skin care industry. Recently, Annette found new inspiration for her work with the introduction of Belli Motherhood and the new beloved Belli Baby collection, which features the purest, gentlest formulations for baby's delicate skin. Her innovative approach to the motherhood/baby category has been profiled in many well-known magazines. Annette is continually motivated by her commitment to women's health and wellness, and volunteers in her off-time with women and children's charities. You can reach Mrs. Rubin at
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
 |